A detailed history of Seven Bridge Financial Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 168,967 shares of PFE stock, worth $4.49 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
168,967
Previous 160,975 4.96%
Holding current value
$4.49 Million
Previous $4.5 Million 8.55%
% of portfolio
0.89%
Previous 0.97%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $221,378 - $250,868
7,992 Added 4.96%
168,967 $4.89 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $94,775 - $111,059
3,752 Added 2.39%
160,975 $4.5 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $151,534 - $174,009
5,853 Added 3.87%
157,223 $4.36 Million
Q4 2023

Jan 22, 2024

BUY
$26.13 - $33.94 $212,358 - $275,830
8,127 Added 5.67%
151,370 $4.36 Million
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $236,888 - $276,898
7,382 Added 5.43%
143,243 $4.75 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $124,036 - $143,506
3,434 Added 2.59%
135,861 $4.98 Million
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $127,269 - $165,685
3,231 Added 2.5%
132,427 $5.4 Million
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $131,596 - $171,784
3,152 Added 2.5%
129,196 $0
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $1.31 Million - $1.61 Million
30,046 Added 31.3%
126,044 $5.52 Million
Q2 2022

Jul 12, 2022

SELL
$46.53 - $55.17 $7,956 - $9,434
-171 Reduced 0.18%
95,998 $5.03 Million
Q1 2022

Apr 15, 2022

SELL
$45.75 - $56.69 $226,920 - $281,182
-4,960 Reduced 4.9%
96,169 $4.98 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $3.9 Million - $5.79 Million
94,505 Added 1426.71%
101,129 $5.97 Million
Q4 2021

Jan 20, 2022

SELL
$41.32 - $61.25 $3.81 Million - $5.65 Million
-92,239 Reduced 93.3%
6,624 $391,000
Q3 2021

Oct 14, 2021

BUY
$39.25 - $50.42 $8,517 - $10,941
217 Added 0.22%
98,863 $4.25 Million
Q2 2021

Jul 26, 2021

BUY
$35.91 - $40.68 $113,583 - $128,670
3,163 Added 3.31%
98,646 $3.86 Million
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $24,983 - $28,176
746 Added 0.79%
95,483 $3.46 Million
Q4 2020

Jan 19, 2021

BUY
$33.47 - $42.56 $95,255 - $121,125
2,846 Added 3.1%
94,737 $3.49 Million
Q3 2020

Oct 22, 2020

BUY
$31.75 - $37.25 $105,918 - $124,266
3,336 Added 3.77%
91,891 $3.37 Million
Q2 2020

Jul 24, 2020

BUY
$30.12 - $36.54 $96,865 - $117,512
3,216 Added 3.77%
88,555 $2.9 Million
Q1 2020

Apr 16, 2020

SELL
$27.03 - $38.62 $86,901 - $124,163
-3,215 Reduced 3.63%
85,339 $2.79 Million
Q4 2019

Jan 17, 2020

SELL
$32.92 - $37.36 $14,978 - $16,998
-455 Reduced 0.51%
88,554 $3.47 Million
Q3 2019

Oct 09, 2019

BUY
$32.49 - $42.13 $134,346 - $174,207
4,135 Added 4.87%
89,009 $3.2 Million
Q2 2019

Jul 15, 2019

BUY
$36.98 - $41.52 $67,303 - $75,566
1,820 Added 2.19%
84,874 $3.68 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $600 - $659
16 Added 0.02%
83,054 $3.53 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $46,894 - $53,465
-1,219 Reduced 1.45%
83,038 $3.63 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $24,956 - $30,270
-724 Reduced 0.85%
84,257 $3.71 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $82,384 - $87,829
2,498 Added 3.03%
84,981 $3.08 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $2,425 - $2,813
-76 Reduced 0.09%
82,483 $2.93 Million
Q4 2017

Feb 20, 2018

BUY
$33.26 - $35.29 $6,053 - $6,422
182 Added 0.22%
82,559 $2.99 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $3,131 - $3,449
-101 Reduced 0.12%
82,377 $2.94 Million
Q2 2017

Aug 14, 2017

BUY
N/A
82,478
82,478 $2.77 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.